Share This

Hot News

京東健康(6618)超額認購421倍! 一手中簽率40% 速查你有無份 @ 2020-12-08T00: Back Hot News
Keyword:京東健康 新股 暗盤
Concept:新股暗盤 , 京東健康一手中簽率
由京東(9618.HK)分拆的京東健康(6618.HK)公布招股結果,共有約84.6萬人認購,超額認購約421倍,中簽人數約41.7萬人,一手中簽率40%,申請者要認購200手才可穩獲1手。股份將於周二(12月8日)上市。據三間證券商的暗盤交易報價,京東健康暗盤升約27%
京東健康公開發售超額420.91倍,獲逾84萬人申請認購,是今年最多人認購的新股;一手認購人數近35.4萬人,中簽率達40%,即有超過14萬「一手黨」抽中,一手中簽率偏高,相對穩中一手的難度就大增,要認購200手穩中一手。至於乙組頭認購則獲分配350股或7手。
周二(8日)掛牌的京東健康 (新上市編號:06618),公布配發結果,有84.6萬人認購,超額認購421倍,凍資5743.5億元,以上限70.58元定價,一手中簽率40%,投資者要認購200手京東健康才可穩獲一手,涉資逾71萬元。今日收市後耀才、輝立及富途證券有暗盤。
【新股IPO】京東健康6618逾84萬人認購 一手中簽率40% 凍資5744億(不斷更新)
公司的股價走暖,為月內入場費最高的榮昌生物上市打下了好的市場氛圍,榮昌生物暗盤階段即受到了市場資金的追捧,由於一手入場門檻高,再加上公司招股期間市場融資資金不足,最終超購倍數為53.43倍,公開市場回撥40%後,一手中簽率高達90%,申請5手穩中一手。上市首日再度大漲33.97%,一手中簽收益高達8850港元,成為近段時間以來最賺錢的新股。
新股暗盤 | 京東健康(6618.HK)暗盤段大漲逾27%

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.